Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pembroke Pines, FL
NPI
1891738720
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
10796 Pines Blvd, Suite 103
Pembroke Pines, FL, 33026
Phone (954) 442-1402
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
1,234 services
Medicare patients, 2024
651
Average age 75
Drug cost, 2024
$6.0M
10,517 prescriptions
Company payments, 2025
$68K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fidel H Henriquez was code 99214 (office e&m - established), 553 times for 342 patients. In total Fidel H Henriquez billed 1,234 services in 15 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 553 | 342 | $92.93 | $51K |
| 99213 Office E&M - Established | Office | 227 | 181 | $66.38 | $15K |
| 77080 Standard X-ray | Facility | 144 | 144 | $9.32 | $1,342 |
| 76536 Ultrasound - Nonspecific | Office | 69 | 69 | $81.59 | $5,630 |
| 99215 Office E&M - Established | Office | 68 | 61 | $134.57 | $9,151 |
| 95251 Test - Miscellaneous | Office | 62 | 45 | $26.29 | $1,630 |
| 99205 Office E&M - New | Office | 50 | 50 | $157.09 | $7,854 |
| 10005 Other Organ Systems | Office | 26 | 24 | $98.49 | $2,561 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 11 | 11 | $11.98 | $132 |
By year: 2022 $143K for 1,884 services; 2023 $125K for 1,975 services; 2024 $97K for 1,234 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fidel H Henriquez prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,013 prescriptions and refills. In total Fidel H Henriquez wrote 10,517 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,013 | 1,507 | 277 | $1.4M |
| Levothyroxine Sodium Generic | 710 | 2,040 | 245 | $7,653 |
| Jardiance Empagliflozin | 665 | 1,596 | 259 | $917K |
| Mounjaro Tirzepatide | 631 | 790 | 117 | $808K |
| Metformin Hcl Generic | 598 | 1,767 | 216 | $2,849 |
| Synthroid Levothyroxine Sodium | 552 | 1,510 | 169 | $62K |
| Losartan Potassium Generic | 309 | 920 | 115 | $2,382 |
| Rosuvastatin Calcium Generic | 301 | 888 | 107 | $2,370 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 300 | 795 | 142 | $26K |
| Pioglitazone Hcl Generic | 296 | 844 | 114 | $3,025 |
| Farxiga Dapagliflozin Propanediol | 261 | 609 | 78 | $327K |
| Atorvastatin Calcium Generic | 261 | 761 | 107 | $1,763 |
| Trulicity Dulaglutide | 259 | 433 | 86 | $421K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 250 | 515 | 86 | $93K |
| Ezetimibe Generic | 200 | 600 | 71 | $2,741 |
Brand drugs: 5,741 claims; generic drugs: 4,199 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fidel H Henriquez $68K ($68K in general payments such as food, travel and fees) from 12 companies. The largest payer was Lilly USA, LLC with $37K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 56 | $37K |
| Novo Nordisk Inc NVO | 31 | $30K |
| Amgen Inc. AMGN | 5 | $228 |
| Madrigal Pharmaceuticals MDGL | 4 | $150 |
| CeQur Corporation | 1 | $57.51 |
| Mannkind Corporation MNKD | 1 | $42.5 |
| Mallinckrodt Hospital Products Inc. | 1 | $31.13 |
| Xeris Pharmaceuticals, Inc. | 1 | $19.8 |
| Saluda Medical Americas, Inc. | 1 | $18.51 |
| Sequel Med Tech, LLC | 1 | $16.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.